Pegylated Human Adrenomedullin

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePegylated Human Adrenomedullin
Drug Alias NameadrenomedullinHM-201HM-101HM101
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAdrenomedullin receptor agonists
TargetsAdrenomedullin receptor
Therapy Area/IndicationsCrohn DiseaseColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHimuka AM Pharma Corp
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCrohn DiseaseColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A